NTII: Neurobiological Technologies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NTII: Neurobiological Technologies

NTII 0.0001000

0.0%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Howard Frederick who wrote (24)	9/18/1997 11:56:00 AM
From: Howard Frederick	of 36

Buried in the Press release, and also the 9/3 press release announcing the Xerecept IND, was the following: Dynorphin A, another human peptide previously tested as an analgesic agent, is available for out-licensing. Apparently management isn't going to develop Dynorphin A in-house.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next